Preliminary results for the year ended 31 December 2020
May 12, 2021 02:00 ET
|
Synairgen plc
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Preliminary results for the year ended 31 December 2020 Significant progress continues towards a treatment for COVID-19 Southampton, UK –...
Osisko Reports Strong First Quarter 2021 Results
May 11, 2021 17:11 ET
|
Osisko Gold Royalties Ltd.
Operating cash flows from royalty and stream segment of $36.7 million Record cash margin of $46.5 million MONTREAL, May 11, 2021 (GLOBE NEWSWIRE) -- Osisko Gold Royalties Ltd (the “Company” or...
ASLAN Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 11, 2021 07:30 ET
|
ASLAN PHARMACEUTICALS LIMITED
- Next data readout for ASLAN004 in the treatment of patients with moderate to severe atopic dermatitis anticipated in the third quarter of 2021 - Phase 2b clinical trial for ASLAN004 expected to...
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
May 10, 2021 16:05 ET
|
Longboard Pharmaceuticals, Inc.
Commenced multiple ascending dose (MAD) portion of the Phase 1 study for LP352, a potential treatment for severe epileptic indications; topline results expected in the second half of 2021 ...
Aemetis to Review First Quarter Financial Results on May 12, 2021
May 10, 2021 08:00 ET
|
Aemetis, Inc.
CUPERTINO, CA, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its first quarter 2021...
BioNTech veröffentlicht Ergebnisse des ersten Quartals 2021 und Informationen zur Geschäftsentwicklung
May 10, 2021 07:00 ET
|
BioNTech SE
Auslieferung von weltweit mehr als 450 Millionen BNT162b2-Impfstoffdosen in 91 Länder oder Regionen bis zum 6. Mai 2021 erfolgtLiefervereinbarungen geschlossen für über 1,8 Milliarden...
BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
May 10, 2021 07:00 ET
|
BioNTech SE
More than 450 million doses of BNT162b2 supplied to 91 countries or territories worldwide as of May 6, 2021Signed agreements for over 1.8 billion doses of BNT162b2 in 2021 and first contracts signed...
Celsion Corporation to Hold First Quarter 2021 Financial Results and Business Update Conference Call on Friday, May 14, 2021
May 07, 2021 08:30 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 06, 2021 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for CRN04894 and CRN04777 expected in mid-2021 SAN DIEGO, May 06, 2021 (GLOBE NEWSWIRE) -- Crinetics...
Misonix Reports Fiscal 2021 Third Quarter Financial Results
May 06, 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...